| CNS | Central Nervous System; 중추신경계 |
|---|---|
| NTV | Nervous Tissue Vaccine; 신경 조직 백신 |
| PNS | Peripheral Nervous System; |
| ANS | acanthion; American Nutrition Society; 8-anilino-1-naphthalene-sulfonic acid; anterior nasal spine; ... |
| ARNMD | Association for Research in Nervous and Mental Diseases |
| coeliac syndrome | <disease, gastroenterology> Gluten enteropathy: atrophy of villi in small intestine leads to impaired absorption of nutrients. Caused by sensitivity to gluten (protein of wheat and rye). Sufferers have serum antibodies to gluten and show delayed hypersensitivity to gluten, the risk factor is ten times greater in HLA B8 positive individuals. (18 Nov 1997) |
|---|---|
| coeliac trunk | Origin, abdominal aorta just below diaphragm; branches, left gastric, common hepatic, splenic. Synonym: truncus coeliacus, arteria coeliaca, coeliac artery, coeliac axis, Haller's tripod. (05 Mar 2000) |
| sprue / coeliac disease | <radiology> Gluten enteropathy, coeliac disease (kids), nontropical sprue (adults), hypersensitivity to gluten, treatment: remove gluten from diet, tropical sprue, clinically and radiologically similar to nontropical sprue, treatment: folate, B-12, antibiotics, associated with ** transient intussusception, oesophageal carcinoma and small bowel carcinoma (QUESTIONABLE!!), diffuse intestinal lymphoma (rare; except in Middle East) (12 Dec 1998) |
| disease, adult coeliac | This condition results from an immune (allergic) reaction to gluten, a protein found in wheat and related grains and present in many foods that we eat. Sprue causes impaired absorption and digestion of nutrients through the small intestine. Symptoms include requent diarrhoea and weight loss. A skin condition called dermatitis herpetiformis can be associated with coeliac sprue. The most accurate diagnostic test for sprue is a biopsy of the involved small bowel. Treatment is to avoid gluten in the diet. Medications are used for refractory (stubborn) sprue. Known under a number of other names, including coeliac sprue. (12 Dec 1998) |
| infantile coeliac disease | Gluten-sensitive enteropathy appearing in infancy, often before the age of 9 months and characterised by acute onset, diarrhoea, abdominal pain, and "failure to thrive." (05 Mar 2000) |
| autonomic nervous system | <anatomy> Neurons that are not under conscious control, comprising two antagonistic components, the sympathetic and parasympathetic nervous systems. The autonomic nervous system regulates key functions including the activity of the cardiac (heart) muscle, smooth muscles (e.g., of the gut), and glands. The autonomic nervous system has two divisions: 1. The sympathetic nervous system that accelerates the heart rate, constricts blood vessels, and raises blood pressure. 2. The parasympathetic nervous system slows the heart rate, increases intestinal and gland activity, and relaxes sphincter muscles. (03 Jul 1999) |
| autonomic nervous system diseases | Diseases that have their major effects on the autonomic nervous system. The autonomic nervous system may be seriously affected in many other disorders including other peripheral nervous system diseases, infectious diseases (e.g., tetanus, diphtheria), immunologic diseases (e.g., acquired immunodeficiency syndrome), and systemic disorders (e.g., diabetic neuropathy, amyloid neuropathy, thyroid diseases). Disorders of central autonomic control also contribute substantially to a wide variety of problems (e.g., eating disorders, panic disorder, water-electrolyte imbalance, cardiovascular diseases). (12 Dec 1998) |
| vegetative nervous system | <anatomy> Neurons that are not under conscious control, comprising two antagonistic components, the sympathetic and parasympathetic nervous systems. The autonomic nervous system regulates key functions including the activity of the cardiac (heart) muscle, smooth muscles (e.g., of the gut), and glands. The autonomic nervous system has two divisions: 1. The sympathetic nervous system that accelerates the heart rate, constricts blood vessels, and raises blood pressure. 2. The parasympathetic nervous system slows the heart rate, increases intestinal and gland activity, and relaxes sphincter muscles. (03 Jul 1999) |
| ventral nervous system defective | <molecular biology> A Drosophila gene encoding an integral membrane glycoprotein related to amyloidogenic glycoprotein. (12 Jan 1998) |
| parasympathetic nervous system | <anatomy, neurology> One of the two divisions of the vertebrate autonomic nervous sytem. Parasympathetic nerves emerge cranially as pre ganglionic fibres from oculomotor, facial, glossopharyngeal and vagus and from the sacral region of the spinal cord. most neurons are cholinergic and responses are mediated by muscarinic receptors. The parasympathetic system innervates, for example: salivary glands, thoracic and abdominal viscera, bladder and genitalia. Compare:. Sympathetic nervous system. (18 Nov 1997) |
| visceral nervous system | <anatomy> Neurons that are not under conscious control, comprising two antagonistic components, the sympathetic and parasympathetic nervous systems. The autonomic nervous system regulates key functions including the activity of the cardiac (heart) muscle, smooth muscles (e.g., of the gut), and glands. The autonomic nervous system has two divisions: 1. The sympathetic nervous system that accelerates the heart rate, constricts blood vessels, and raises blood pressure. 2. The parasympathetic nervous system slows the heart rate, increases intestinal and gland activity, and relaxes sphincter muscles. (03 Jul 1999) |
| central nervous system | <anatomy, neurology> Pertaining to the brain, cranial nerves and spinal cord. It does not include muscles or peripheral nerves. In invertebrates, the central nervous system is composed of the segmental ganglia of the ventral nerve cord together with the fused ganglia or brain at the anterior end. Acronym: CNS (12 Jan 1998) |
| central nervous system agents | A class of drugs producing both physiological and psychological effects through a variety of mechanisms. They can be divided into "specific" agents, e.g., affecting an identifiable molecular mechanism unique to target cells bearing receptors for that agent, and "non-specific" agents, those producing effects on different target cells and acting by diverse molecular mechanisms. Those with non-specific mechanisms are generally further classed according to whether they produce behavioural depression or stimulation. Those with specific mechanisms are classed by locus of action or specific therapeutic use. (12 Dec 1998) |
| central nervous system depressants | A very loosely defined group of drugs that tend to reduce the activity of the central nervous system. The major groups included here are ethyl alcohol, anaesthetics, hypnotics and sedatives, narcotics, and tranquillising agents (antipsychotics and antianxiety agents). (12 Dec 1998) |
| central nervous system infections | Diseases of the central nervous sytem collectively, caused by pathogenic organisms. (12 Dec 1998) |